| |
| |
|
| Insider
Information: |
White William Richard |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
49,630 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
49,630 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akero Therapeutics, Inc. |
AKRO |
|
2024-03-13 |
49,630 |
2019-12-31 |
0 |
Premium* |
|
|
Ventyx Biosciences, Inc. |
VTYX |
Director |
2023-01-23 |
0 |
2023-01-23 |
0 |
Premium* |
|
|
Disc Medicine, Inc |
IRON |
|
2024-05-01 |
0 |
2023-12-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IRON |
Disc Medicine, Inc |
|
– • – |
2024-05-01 |
4 |
AS |
$28.52 |
$5,755 |
D/D |
(201) |
0 |
0 |
% |
|
| IRON |
Disc Medicine, Inc |
|
– • – |
2024-05-01 |
4 |
OE |
$9.86 |
$1,982 |
D/D |
201 |
201 |
0 |
- |
|
| IRON |
Disc Medicine, Inc |
|
– • – |
2024-04-11 |
4 |
AS |
$31.79 |
$81,407 |
D/D |
(2,560) |
0 |
0 |
% |
|
| IRON |
Disc Medicine, Inc |
|
– • – |
2024-04-11 |
4 |
OE |
$2.65 |
$12,581 |
D/D |
2,560 |
2,560 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2024-03-13 |
4 |
S |
$28.33 |
$20,511 |
D/D |
(724) |
49,630 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-12-14 |
4 |
S |
$20.76 |
$12,684 |
D/D |
(611) |
50,354 |
0 |
- |
|
| IRON |
Disc Medicine, Inc |
|
– • – |
2023-12-12 |
4 |
S |
$59.44 |
$2,118,239 |
D/D |
(33,511) |
0 |
0 |
% |
|
| IRON |
Disc Medicine, Inc |
|
– • – |
2023-12-12 |
4 |
OE |
$2.65 |
$203,883 |
D/D |
33,511 |
33,511 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
32,497 |
50,965 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-09-13 |
4 |
AS |
$50.34 |
$31,815 |
D/D |
(632) |
18,468 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-06-20 |
4 |
S |
$55.00 |
$1,142,735 |
D/D |
(20,777) |
19,100 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-06-20 |
4 |
OE |
$7.01 |
$122,658 |
D/D |
17,500 |
39,877 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-06-13 |
4 |
AS |
$55.16 |
$33,427 |
D/D |
(606) |
22,377 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-03-10 |
4 |
D |
$43.47 |
$27,864 |
D/D |
(641) |
22,983 |
0 |
- |
|
| VTYX |
Ventyx Biosciences, Inc. |
Director |
– • – |
2023-01-23 |
4 |
AS |
$34.33 |
$1,170,592 |
D/D |
(33,353) |
0 |
0 |
% |
|
| VTYX |
Ventyx Biosciences, Inc. |
Director |
– • – |
2023-01-23 |
4 |
OE |
$6.03 |
$201,119 |
D/D |
33,353 |
33,353 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-12-28 |
4 |
AS |
$49.76 |
$49,714 |
D/D |
(999) |
23,624 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-12-28 |
4 |
OE |
$7.01 |
$7,002 |
D/D |
999 |
24,623 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-12-27 |
4 |
OE |
$7.01 |
$133,178 |
D/D |
19,001 |
42,625 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-12-27 |
4 |
AS |
$49.77 |
$945,609 |
D/D |
(19,001) |
23,624 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
19,195 |
23,624 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-10-13 |
4 |
AS |
$39.82 |
$796,400 |
D/D |
(20,000) |
4,429 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-10-13 |
4 |
OE |
$7.01 |
$140,180 |
D/D |
20,000 |
24,429 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-09-13 |
4 |
AS |
$26.42 |
$878,341 |
D/D |
(32,500) |
4,429 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-09-13 |
4 |
OE |
$7.01 |
$227,793 |
D/D |
32,500 |
36,929 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
